Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature
- PMID: 39140381
- PMCID: PMC11383744
- DOI: 10.1097/MCD.0000000000000490
Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature
Abstract
Introduction: Biallelic variants in thiamine pyrophosphokinase 1 ( TPK1 ) are known to cause thiamine metabolism dysfunction syndrome 5 (THMD5). This disorder is characterized by neuroregression, ataxia and dystonia with basal ganglia abnormalities on neuroimaging. To date, 27 families have been reported with THMD5 due to variants in TPK1 .
Methods: We ascertained three individuals from three unrelated families. Singleton exome sequencing was performed on all three individuals, followed by in silico mutagenesis of the mutant TPK protein. Additionally, we reviewed the genotypic and phenotypic information of 27 previously reported individuals with THMD5.
Results: Singleton exome sequencing revealed a novel homozygous variant c.620A>T p.(Asp207Val) in TPK1 (NM_022445.4) in all three individuals. In silico mutagenesis of the mutant protein revealed a decrease in protein stability and altered interactions with its neighboring residues compared to the wild-type protein. Thus, based on strikingly similar clinical and radiological findings compared to the previously reported individuals and with the support of in silico mutagenesis findings, the above-mentioned variant appears to be the probable cause for the condition observed in the affected individuals in this study.
Conclusion: We report a novel homozygous variant in TPK1 , which appears to be recurrent among the Indian population.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures
References
-
- Au LWC, Lee HHC, Sheng B, Chan KY, Yau EKC, Mak CM, et al. (2020). Movement disorders associated with thiamine pyrophosphokinase deficiency: Intrafamilial variability in the phenotype. Clin Neurol Neurosurg, 199:106258. - PubMed
-
- Banka S, de Goede C, Yue WW, Morris AA, von Bremen B, Chandler KE, et al. (2014). Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab, 113:301–306. - PubMed
-
- Eckenweiler M, Mayr JA, Grünert S, Abicht A, Korinthenberg R (2021). Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants. Neuropediatrics, 52:123–125. - PubMed
-
- Ferreira-Vieira TH, de Freitas-Silva DM, Ribeiro AF, Pereira SR, Ribeiro  (2016). Perinatal thiamine restriction affects central GABA and glutamate concentrations and motor behavior of adult rat offspring. Neurosci Lett, 617:182–187. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
